| PTH | parathyroid hormone |
| CaSR | calcium sensing receptor |
| EGFR | epidermal growth factor receptor |
| mTOR | mammalian target of rapamycin |
| SHP | secondary hyperparathyroidism |
| CKD | chronic kidney disease |
| TGF-α | transforming growth factor α |
| 1,25D | 1,25 dihydroxyvitamin D |
| NF-kB | nuclear factor kappa B |
| Cox-PGE | cyclo-oxygenase- prostaglandin E |
| VDR | vitamin D receptor |
| FGFR1 | fibroblast growth factor receptor |
| miRNA | micro-RNA |
| APRT | adenine phosphoribosyltransferase |
| MAPK | mitogen-activated protein kinase |
| eIF-4E | eukaryotic translation initiation factor-4E |
| PRAD1 | parathyroid adenomatosis 1 |
| MEN1 | multiple endocrine neoplasia type 1 |
| RET | rearranged during transfection |
| CKI | cyclin-dependent kinase inhibitor |
| AKT | protein kinase B |
| 4E-BP1 | 4E binding protein 1 |
| PCNA | proliferating cell nuclear antigen |
| PDTC | ammonium pyrrolidinedithiocarbamate |
| PGE2 | prostaglandin E2 |
| EP2 | PGE2 receptor 2 subtype |
| PT-Dicer-/- mice | Parathyroid specific dicer knockout mice |